30
Views
69
CrossRef citations to date
0
Altmetric
Original Article

The Diagnostic Validity of the Serum Tumor Marker Phosphohexose Isomerase (PHI) in Patients with Gastrointestinal, Kidney, and Breast Cancer

, , , , &
Pages 351-356 | Published online: 11 Jun 2009

References

  • Schwartz M K, Greenberg E, Bodansky O. Comparative values of phosphatases and other serum enzymes in following patients with prostatic carcinoma. Consideration of phosphohexose isomerase, glutamic oxalacetic transaminase, isocitric dehydrogenase, and acid and alkaline phosphatases. Cancer 1963; 16: 583–594
  • Griffith M M, Beck J C. The value of serum phosphohexose isomerase as an index of metastatic breast carcinoma activity. Cancer 1963; 16: 1032–1041
  • Joplin G F, Jegatheesan K A. Serum glycolytic enzymes and acid phosphatases in mammary carcinomatosis. Br Med J 1962; 5281: 827–831
  • Rose A, West M, Zimmermann H J. Serum enzymes in disease. V. Isocitric dehydrogenase, malic dehydrogenase, and glycolytic enzymes in patients with carcinoma of the breast. Cancer 1961; 14: 726–733
  • Damle S R, Talavdekar R V, Panse T B. Studies on Glycolytic Enzymes in relation to cancer, Part III: Clinical significance of serum phosphohexose isomerase and aldolase in cancer of the prostate. A comparative study with serum acid phosphatase and serum alkaline phosphatase. Ind J Cancer 1971; 9: 176–184
  • Schwartz M K. Enzymes in cancer. Clin Chem 1973; 19: 10–22
  • Schwartz M K. Laboratory aids to diagnosis: Enzymes. Cancer 1976; 37: 542–548
  • Uhlenbruck G, Dati F. Zur Labordiagnostik von Tumorerkrankungen. Diagnose Labor 1986; 35: 41–55
  • Chaput M, Claes V, Portetelle D, et al. The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase. Nature (Lond) 1988; 332: 455–456
  • Faik P, Walker J I, Redmill A AM, Morgan M J. Mouse glucose-6-phosphate isomerase and neuroleukin have identical 3′ sequences. Nature (Lond) 1988; 332: 456–457
  • Gurney M E. Gurney replies. Nature (Lond) 1988; 332: 456–457
  • Baumann M, Brand K. Purification and characterization of phosphohexose isomerase from human gastrointestinal carcinoma and its potential relationship to neuroleukin. Cancer Res 1988; 48: 7018–7021
  • Gurney M E, Heinrich S P, Lee M R, Yin H-S. Molecular cloning and expression of neuroleukin a neurotrophic factor for spinal and sensory neurons. Science (Washington DC) 1986; 234: 566–574
  • Gurney M E, Apatoff B R, Spear G T, et al. Neuroleukin: a lymphokine product of lectin-stimulated T-cells. Science (Washington DC) 1986; 234: 574–581
  • Harmer M. UICC TNM Classification of Malignant Tumours, 3rd ed. UICC, Geneva 1982, 1978, enlarged and revised
  • Robson C J, Churchill B M, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 1969; 101: 297–301
  • Bergmeyer H U, Grassl M, Walter H-E. Phosphoglucose isomerase. Methods of Enzymatic Analysis, 3rd ed, H U Bergmeyer. Verlag Chemie, Weinheim 1983; Vol II: 279–280
  • Kaiko S H, Mizuno K. Sensitive assay system for detection of hemoglobin with 2,7-diaminofIuorene: Histochemistry and colorimetry for erythrodifferentiation. Anal Biochem. 1985; 149: 117–120
  • Schwartz M K. Tumor markers in the patient with lung cancer (abstr). Third International Conference on Human Tumor Markers. Biology and Clinical Applications., Naples, 1986, 48–49, Abstract Book
  • Bowen M, de Mello J, Cooper E H. The clinical significance of phosphohexose isomerase levels in gastrointestinal and breast cancer. Tumor Diagnostik 1981; 2: 22–26
  • Schneider J. Tumormarker in der Diagnostik maligner Prozesse. Diagnostik 1985; 18: 25
  • Baumann M, Brand K, Giedl J, et al. Significance of serum phosphohexose isomerase in gastrointestinal cancer at different stages. Oncology 1988; 45: 153–158

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.